Latest trade
$17.1BGlobal subsector valueHS4 subsector intelligence
Medicaments
HS4 3003 trade overview
A focused view of this HS4 subsector: market scale, momentum, leading routes, countries, and the HS6 classifications inside it.
The numbers at a glanceLatest reported year · 2024
Annual change
+112%Latest year on yearExporters
156Active reporting countriesImporters
200Active reporting countriesHS6 products
10Classifications inside HS4The subsector read
$17.1B in trade, with +23% annualized growth over three years.
Medicaments is recorded across 4,176 active corridors, with 156 exporters and 200 importers.
Annual trend
Subsector momentum over time
Reported global trade from 1995 to 2024. Read the methodology ↗
Top trade corridors
Where the subsector moves
Leading exporter-to-importer relationships by latest reported value. See data sources ↗
Latest reported relationshipsTop 10 by trade value
| Rank | Exporter | Importer | Trade value | Growth | HS6 | Distance | FTA |
|---|---|---|---|---|---|---|---|
| 1 | IrelandIRL | BelgiumBEL | $3.6B | +448.1% | 4 | 776 km | Yes |
| 2 | PortugalPRT | USA, Puerto Rico and US Virgin IslandsUSA | $900.5M | +126.2% | 2 | 5,435 km | No |
| 3 | USA, Puerto Rico and US Virgin IslandsUSA | GermanyDEU | $864.8M | +36% | 4 | 6,402 km | No |
| 4 | PortugalPRT | GermanyDEU | $451.1M | +174.3% | 2 | 2,316 km | Yes |
| 5 | Switzerland, LiechtensteinCHE | SpainESP | $413.9M | +40.3% | 4 | 1,245 km | Yes |
| 6 | IrelandIRL | PortugalPRT | $279.2M | +705.1% | 4 | 1,640 km | Yes |
| 7 | SingaporeSGP | USA, Puerto Rico and US Virgin IslandsUSA | $275.5M | +3.1% | 1 | 15,347 km | Yes |
| 8 | ItalyITA | USA, Puerto Rico and US Virgin IslandsUSA | $247.6M | +36.2% | 6 | 6,907 km | No |
| 9 | USA, Puerto Rico and US Virgin IslandsUSA | IrelandIRL | $236.7M | -23.4% | 6 | 5,129 km | No |
| 10 | USA, Puerto Rico and US Virgin IslandsUSA | BelgiumBEL | $217.1M | +104.6% | 5 | 5,904 km | No |
Market structure
Where supply and demand concentrate
Exporter and importer rankings show the two sides of the subsector separately. Check coverage ↗
| Rank | Country | Exports | Partners | HS6 |
|---|---|---|---|---|
| 1 | IrelandIRL | $4.4B | 67 | 9 |
| 2 | USA, Puerto Rico and US Virgin IslandsUSA | $2.0B | 144 | 10 |
| 3 | PortugalPRT | $1.7B | 56 | 9 |
| 4 | ChinaCHN | $1.1B | 155 | 10 |
| 5 | ItalyITA | $893.3M | 106 | 10 |
| 6 | GermanyDEU | $871.8M | 111 | 10 |
| 7 | Switzerland, LiechtensteinCHE | $854.8M | 107 | 10 |
| 8 | SpainESP | $572.9M | 93 | 10 |
| 9 | BelgiumBEL | $556.3M | 116 | 10 |
| 10 | FranceFRA | $502.6M | 129 | 10 |
| Rank | Country | Imports | Partners | HS6 |
|---|---|---|---|---|
| 1 | BelgiumBEL | $4.0B | 44 | 10 |
| 2 | USA, Puerto Rico and US Virgin IslandsUSA | $2.2B | 62 | 10 |
| 3 | GermanyDEU | $2.1B | 73 | 10 |
| 4 | SpainESP | $666.8M | 50 | 10 |
| 5 | IrelandIRL | $630.7M | 59 | 9 |
| 6 | NetherlandsNLD | $533.4M | 65 | 10 |
| 7 | JapanJPN | $471.1M | 31 | 10 |
| 8 | ChinaCHN | $438.3M | 38 | 10 |
| 9 | ItalyITA | $397.4M | 50 | 10 |
| 10 | PortugalPRT | $348.7M | 35 | 9 |
HS6 product coverage
The products inside HS4 3003
Six-digit classifications make the subsector specific. Browse the product workspace ↗
11 classifications shownMedicaments
Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale)HS6 300310
Medicaments: containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale)HS6 300320
Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail saleHS6 300331
Medicaments: containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail saleHS6 300339
Medicaments: containing alkaloids or their derivatives, (but not containing hormones or antibiotics), for therapeutic or prophylactic uses, (not packaged for retail sale)HS6 300340
Medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)HS6 300341
Medicaments: containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)HS6 300342
Medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)HS6 300343
Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, (not packaged for retail sale)HS6 300349
Medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, (not packaged for retail sale)HS6 300360
Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)HS6 300390
Definitions and coverage
Read the numbers with context
Reported observations and calculated indicators should be read with their coverage period. Responsible AI principles ↗
Reported values
Trade values describe reported merchandise trade for the HS4 classification, not company-level sales or shipment records.
Calculated indicators
Growth, concentration, volatility, and peak comparisons are calculated from reported observations.
Missing data
Unavailable observations remain unavailable. They are not filled, interpolated, or presented as forecasts.
Coverage: 1995-2024 · Data refreshed 2026-07-20 09:34:09
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-27). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.